|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2000-09-28 |
The Effect of Vaginal Mifepristone on Reduction of Uterine Fibroids Size and the Symptoms Associated With the Fibroids - Pilot Study (Phase IIa)
The purpose of this study is to evaluate the effect of daily dosage of vaginally mifepristone on reduction of uterine fibroids size and the symptoms associated with uterine fibroids.
100 项与 BioPro Medical Ltd 相关的临床结果
0 项与 BioPro Medical Ltd 相关的专利(医药)
100 项与 BioPro Medical Ltd 相关的药物交易
100 项与 BioPro Medical Ltd 相关的转化医学